AMZN vs MRM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Amazon exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and a healthy Debt/Equity ratio of 0.43. While the current price of $221.25 represents a significant premium over the Graham Number ($79.92) and Intrinsic Value ($107.45), this is typical for a high-growth dominant player in the internet retail and cloud space. Strong revenue growth (13.6%) and a superior ROE (22.29%) compared to the sector average (4.42%) justify the valuation premium. Despite bearish insider selling, the strong analyst consensus and consistent earnings beat history support a positive long-term outlook.
MRM presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe underlying liquidity distress. While the stock trades below its Graham Number ($1.27) and Intrinsic Value ($2.59), these valuation metrics are overshadowed by a catastrophic Current Ratio of 0.24 and an extreme Debt/Equity ratio of 7.86. The company is experiencing declining revenue growth (-6.70%) and deep operating losses (-25.84% margin), suggesting that the nominal net profit is likely driven by non-operating items rather than core business health.
Compare Another Pair
Related Comparisons
AMZN vs MRM: Head-to-Head Comparison
This page compares Amazon.com, Inc. (AMZN) and MEDIROM Healthcare Technologies Inc. (MRM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.